| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 404 | 1,717 | 3,190 | 4,024 | | Cost of Revenue | 491 | 2,134 | 5,546 | 16,118 | | | Gross Profit | (88) | (417) | (2,357) | (12,094) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,418 | 1,386 | 4,197 | 5,852 | | Non Recurring | (246) | (9,341) | 157 | 17,726 | | Others | 1,064 | 1,083 | 1,063 | 1,496 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,184) | 6,455 | (7,774) | (37,169) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 878 | 73 | 37 | 56 | | Earnings Before Interest And Taxes | (5,366) | 6,545 | (7,694) | (37,114) | | Interest Expense | 1,518 | 1,554 | 1,455 | 1,664 | | Income Before Tax | (6,885) | 4,990 | (9,149) | (38,777) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | (0) | 16 | 44 | 88 | | | | Net Income From Continuing Ops | (3,964) | 4,990 | (9,149) | (38,690) | | | Non-recurring Events | | Discontinued Operations | 588 | (315) | 649 | (533) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,376) | 4,675 | (8,500) | (39,222) | | Preferred Stock And Other Adjustments | (147) | (226) | (247) | (916) | | | Net Income Applicable To Common Shares | ($3,523) | $4,449 | ($8,747) | ($40,138) |
|
0.08% Nasdaq 
0.28%
Income Statement
